{
    "nctId": "NCT03120390",
    "briefTitle": "Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors",
    "officialTitle": "Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity: The ROSA Trial (Phase II, Randomized Controlled Trial for Early Stage Breast Cancer Survivors)",
    "overallStatus": "WITHDRAWN",
    "conditions": "Cancer Survivor, Central Obesity, No Evidence of Disease",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Change in MetD",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Newly diagnosed (stage I-III) breast cancer\n* Self-identify as Latina\n* Have undergone a lumpectomy or mastectomy\n* Have received and completed neoadjuvant or adjuvant cytotoxic chemotherapy and/or radiation therapy within the past 12 months\n* Have no evidence of cancer disease after treatment (confirmed by their treating physician)\n* Able to initiate a supervised exercise program (free from any cardiovascular, respiratory or musculoskeletal disease or joint problems that preclude moderate physical activity; obtains clearance from physician to confirm status)\n* Are centrally obese with the following criteria (determined by study team at eligibility screening): body mass index (BMI) \\> 30 kg/m\\^2 (calculated using height and weight) or body fat \\> 30% (estimated by bioelectrical impedance), and waist circumference \\> 35 inches (in)\n* Free from history of chronic disease including severe diabetes (glycosylated hemoglobin \\[HgA1c\\] \\> 7% requiring a pharmacologic intervention), uncontrolled hypertension or thyroid disease (obtains clearance from physician to confirm status)\n* Have not experienced a weight reduction \\>= 10% within past 6 months; and body weight has remained stable for the past 4 weeks\n* Currently participate in less than 60 minutes of physical activity/week\n* No planned reconstructive surgery with flap repair during trial and follow-up period\n* May use adjuvant endocrine therapy if use will be continued for duration of study period\n* Does not smoke (no smoking during previous 12 months)\n* Willing to travel to the exercise facility at University of Southern California (USC) (parking fees and public transportation permits will be provided)\n\nExclusion Criteria:\n\n* Currently pregnant\n* History of chronic disease including uncontrolled diabetes, uncontrolled hypertension or uncontrolled thyroid disease; women using metformin to manage diabetes will be excluded from the trial\n* Weight reduction \\>= 10% within past 6 months\n* Metastatic disease\n* Planned reconstructive surgery with flap repair during trial and follow-up period\n* Cardiovascular, respiratory or musculoskeletal disease or joint problems that preclude moderate physical activity",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}